Seah H. Lim

Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities

Raman Desikan, Bart Barlogie, Jeffrey R. Sawyer et al. · Blood · 2000 · 319 citations

Phase 1 clinical trial of adoptive immunotherapy using “off-the-shelf” activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia

Michael Boyiadzis, Mounzer Agha, Robert L. Redner et al. · Cytotherapy · 2017 · 170 citations

Hematological Malignancy, Cell Therapy, Medicine +11

Use of broad-spectrum antibiotics impacts outcome in patients treated with immune checkpoint inhibitors

Jibran Ahmed, Arun Kumar, Kaushal Parikh et al. · OncoImmunology · 2018 · 169 citations · Full text

Idiotypic protein-pulsed dendritic cell vaccination in multiple myeloma

Seah H. Lim, R Bailey-Wood · International Journal of Cancer · 1999 · 160 citations

Sperm protein 17 is a novel cancer-testis antigen in multiple myeloma

Seah H. Lim, Zhiqing Wang, Maurizio Chiriva‐Internati et al. · Blood · 2001 · 131 citations · Full text